Latest News about CRSP
Recent news which mentions CRSP
Gene Therapy For Beta-Thalassemia: CRISPR Therapeutics/Vertex's Casgevy Secures FDA Nod Ahead of Schedule
January 17, 2024
From Benzinga
Cathie Wood's Ark Invest Liquidates $15.8M Worth Of ProShares Bitcoin Strategy ETF Units
January 16, 2024
From Benzinga
These 2 Stocks Carry a Lot of Risk, but Their Upside Is Huge
January 16, 2024
From Motley Fool
Here's Why CRISPR Therapeutics Stock Rose 54% Last Year
January 15, 2024
From Motley Fool
5 Biotech Stocks That Could Be Big Winners in 2024 and Beyond
January 15, 2024
From Motley Fool
Down 88%, Could Editas Medicine Be a Good Investment Now?
January 15, 2024
From Motley Fool
Tickers
CRSP
From Motley Fool
7 Healthcare Stocks Taking Medicine to the Next Level
January 14, 2024
From InvestorPlace
My 3 Highest-Conviction Growth Stocks to Buy in 2024
January 14, 2024
From Motley Fool
My 5 Top Growth Stocks to Buy Hand Over Fist for 2024
January 14, 2024
From Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought This Week
January 13, 2024
From Motley Fool
2 Red Flags for Bluebird Bio Stock
January 10, 2024
From Motley Fool
3 Cathie Wood Stocks to Start Off Your New Year Right
January 10, 2024
From Motley Fool
The Ultimate Growth Stock to Buy With $1,000 Right Now
January 08, 2024
From Motley Fool
From Motley Fool
2 Biotech Stocks With Huge Catalysts in 2024
January 05, 2024
From Motley Fool
Gen Z’s Top Picks for 2024: 7 Trending Stocks Among Young Investors
January 04, 2024
From InvestorPlace
Here's Why 2024 Could Be a Big Year for CRISPR Therapeutics
January 04, 2024
From Motley Fool
From InvestorPlace
Better Risky Investment: Bluebird Bio vs. Shiba Inu
January 03, 2024
From Motley Fool
3 Biotech Stocks Set for Breakthroughs in 2024
January 02, 2024
From InvestorPlace
Here's How Much $100 Invested In CRISPR Therapeutics 5 Years Ago Would Be Worth Today
January 01, 2024
From Benzinga
3 No-Brainer Growth Stocks to Buy for Less Than $100
January 01, 2024
From Motley Fool
1 Cathie Wood Stock Worth Buying Hand Over Fist in 2024
December 31, 2023
From Motley Fool
2 Gene-Editing Stocks That Might Be the Next CRISPR Therapeutics
December 31, 2023
From Motley Fool
2023 in Review: Nvidia, Interest Rates, Taylor Swift
December 30, 2023
From Motley Fool
3 Stocks That Could Be Monster Winners in 2024
December 30, 2023
From Motley Fool
From InvestorPlace
3 Top Stocks to Buy Hand Over Fist Before the End of 2023
December 25, 2023
From Motley Fool
3 Healthcare Technology Stocks to Improve Lives in 2024
December 25, 2023
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.